Function acquires SuppCo to tackle the supplements trust gap
What's the deal? Function, a health data platform, has acquired SuppCo, a startup that independently tests and rates dietary supplements. The deal brings SuppCo's supplement verification technology under Function's roof, combining lab-tested product ratings with Function's existing health tracking tools.
Function aims to use SuppCo's capabilities to help consumers navigate the notoriously opaque supplements market, where products often contain different ingredients or dosages than what's listed on the label.
Why now? The global dietary supplements market continues to grow rapidly, yet consumer trust remains a persistent problem. Studies have repeatedly shown that many supplements fail third-party testing for label accuracy, purity, or potency. Regulatory oversight in the US remains limited — the Food and Drug Administration does not approve supplements before they reach shelves.
By integrating SuppCo's independent testing data, Function positions itself as a one-stop platform where users can track their health metrics and make evidence-based decisions about the products they consume.
What could go wrong? Independent supplement testing is a niche but contentious space. Brands whose products score poorly could push back, creating legal or reputational challenges. Scaling lab-based verification across the vast supplements market — estimated at over $150B globally — is also resource-intensive, and maintaining testing rigour while growing quickly is no small feat.
There's also the question of consumer behaviour: even with better data, many supplement buyers make purchasing decisions based on marketing, influencer endorsements, or habit rather than independent ratings.
The signal: This acquisition reflects a broader trend of health-tech companies moving beyond data collection toward actionable, trust-building tools. As consumers demand more transparency in wellness products, platforms that can verify claims — not just track outcomes — stand to capture outsized value. Function is betting that the next frontier in personalised health isn't just knowing your biomarkers, but knowing whether the products you take actually deliver what they promise.
Read more: prnewswire.com
